No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Dysgerminoma / drug therapy*
-
Humans
-
Male
-
Risk Factors
-
Testicular Neoplasms / drug therapy*